Filing Details

Accession Number:
0001209191-22-011731
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-22 16:59:33
Reporting Period:
2022-02-14
Accepted Time:
2022-02-22 16:59:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828522 Effector Therapeutics Inc. EFTR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1293973 B Christopher Ehrlich C/O Effector Therapeutics, Inc.
142 North Cedros Avenue, Suite B
Solana Beach CA 92075
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-14 2,000 $4.45 15,000 No 4 P Direct
Common Stock Acquisiton 2022-02-18 1,000 $4.30 16,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 142,168 Indirect By Locust Walk Partners LLC
Common Stock 1,034 Indirect By Locust Walk Partners LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
  3. Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.